{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:27:42Z","timestamp":1788460062509,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.eururo.2013.01.002","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T17:29:26Z","timestamp":1357925366000},"page":"74-81","source":"Crossref","is-referenced-by-count":113,"title":["Randomised, Multicentre, Placebo-controlled, Double-blind Crossover Study Investigating the Effect of Solifenacin and Oxybutynin in Elderly People with Mild Cognitive Impairment: The SENIOR Study"],"prefix":"10.1016","volume":"64","author":[{"given":"Adrian","family":"Wagg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Tretter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Stow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Compion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2013.01.002_bib0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/nau.20737","article-title":"Reviewing the ICS 2002 terminology report: the ongoing debate","volume":"28","author":"Abrams","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2013.01.002_bib0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2013.01.002_bib0015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.urology.2010.08.039","article-title":"National community prevalence of overactive bladder in the United States stratified by sex and age","volume":"77","author":"Coyne","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2013.01.002_bib0020","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.eursup.2006.07.008","article-title":"Managing special populations: the elderly","volume":"5","author":"Wagg","year":"2006","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2013.01.002_bib0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MOU.0b013e3283468da3","article-title":"Update on the treatment of overactive bladder","volume":"21","author":"Dmochowski","year":"2011","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2013.01.002_bib0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1755-5949.2011.00248.x","article-title":"Anticholinergics for overactive bladder therapy: central nervous system effects","volume":"18","author":"Chancellor","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.eururo.2013.01.002_bib0035","first-page":"42","article-title":"The cognitive burden of anticholinergics in the elderly \u2013 implications for the treatment of overactive bladder","volume":"7","author":"Wagg","year":"2012","journal-title":"Eur Urol Rev"},{"key":"10.1016\/j.eururo.2013.01.002_bib0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2006.05.016","article-title":"Microvascular injury and blood-brain barrier leakage in Alzheimer's disease","volume":"28","author":"Zipser","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.eururo.2013.01.002_bib0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","article-title":"Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging","volume":"74","author":"Starr","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.eururo.2013.01.002_bib0050","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","article-title":"Blood-brain barrier disruption in multiple sclerosis","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult Scler"},{"issue":"Suppl 2","key":"10.1016\/j.eururo.2013.01.002_bib0055","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.5489\/cuaj.11188","article-title":"Treating overactive bladder in the elderly","volume":"5","author":"Wagg","year":"2011","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2013.01.002_bib0060","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/14740330903260790","article-title":"Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10mg","volume":"8","author":"Wesnes","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.eururo.2013.01.002_bib0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1532-5415.1998.tb01006.x","article-title":"Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride","volume":"46","author":"Katz","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.eururo.2013.01.002_bib0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.eururo.2006.03.057","article-title":"Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects","volume":"50","author":"Kay","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.01.002_bib0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.ju.0000148963.21096.5d","article-title":"Assessment of cognitive function of the elderly population: effects of darifenacin","volume":"173","author":"Lipton","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.01.002_bib0080","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2014beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.eururo.2013.01.002_bib0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.eururo.2013.01.002_bib0090","series-title":"Clinical Gerontology: A Guide to Assessment and Intervention","first-page":"165","article-title":"Geriatric depression scale (GDS). Recent evidence and development of a shorter version","author":"Sheikh","year":"1986"},{"key":"10.1016\/j.eururo.2013.01.002_bib0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2125.2000.00131.x","article-title":"Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers","volume":"49","author":"Wesnes","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.eururo.2013.01.002_bib0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.31887\/DCNS.2000.2.3\/kwesnes","article-title":"The value of assessing cognitive function in drug development","volume":"2","author":"Wesnes","year":"2000","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.eururo.2013.01.002_bib0105","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMcp0910237","article-title":"Clinical practice. Mild cognitive impairment","volume":"364","author":"Petersen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2013.01.002_bib0110","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/01.JGP.0000224619.87681.71","article-title":"Long-term cognitive impact of anticholinergic medications in older adults","volume":"14","author":"Bottiggi","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.eururo.2013.01.002_bib0115","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","article-title":"Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study","volume":"59","author":"Fox","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.eururo.2013.01.002_bib0120","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/j.1532-5415.2008.02009.x","article-title":"Cumulative anticholinergic exposure is associated with poor memory and executive function in older men","volume":"56","author":"Han","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.eururo.2013.01.002_bib0125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1532-5415.2010.03307.x","article-title":"Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay","volume":"59","author":"Jakobsen","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.eururo.2013.01.002_bib0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.2011.03961.x","article-title":"A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder","volume":"72","author":"Callegari","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.eururo.2013.01.002_bib0135","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1532-5415.2008.01680.x","article-title":"Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence","volume":"56","author":"Lackner","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.eururo.2013.01.002_bib0140","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1532-5415.2008.01681.x","article-title":"Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes","volume":"56","author":"Sink","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.eururo.2013.01.002_bib0145","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1017\/S1041610209990664","article-title":"Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease","volume":"21","author":"Isik","year":"2009","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.eururo.2013.01.002_bib0150","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1532-5415.2009.02369.x","article-title":"How to manage overactive bladder in elderly individuals with dementia? A combined use of donepezil, a central acetylcholinesterase inhibitor, and propiverine, a peripheral muscarine receptor antagonist","volume":"57","author":"Sakakibara","year":"2009","journal-title":"J Am Geriatr Soc"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T14:59:44Z","timestamp":1644073184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283813000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0302283813000055"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2013.01.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717976561.793472229","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717976561.793472207","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717976561.793472808","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717976561.793471287","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717976561.793471800","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717976561.793471699","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}